Enterococcus Faecalis Infection
7
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis"
The Effect of Ca(OH)2 in Apical Periodontitis
Antimicrobial Efficacy of Nano-Based ICM on E.F
Quantitative Assessment of the Efficacy of Two Irrigation Activation Systems
Quantitative Assessment of the Efficacy of Sweeps Laser Activation Systems
Combination Treatment for Enterococcus Faecalis Bacteriemia Multicenter, Observational Study"